The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kima, P. E.
Right arrow Articles by McMahon-Pratt, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kima, P. E.
Right arrow Articles by McMahon-Pratt, D.

The Journal of Immunology, Vol 159, Issue 4 1828-1834, Copyright © 1997 by American Association of Immunologists


ARTICLES

Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells

PE Kima, NH Ruddle and D McMahon-Pratt
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA.

CD8+ T cells play a protective role in immunity to cutaneous leishmaniasis. However, it has been unclear how these cells execute this function, since results from several investigations attempting to demonstrate recognition of Leishmania-infected macrophages by CD8+ T cells have been contradictory. In this study, we report the generation of CD8+ T cell lines specific for GP46/M-2, a leishmanial Ag, previously shown to protectively immunize mice against a Leishmania amazonensis challenge. Using T cell cytolysis and IFN-gamma production to assess CD8+ T cell activation, we show that in addition to recognizing mammalian cells transfected with GP46/M-2, these CD8+ T cell lines also recognize macrophages infected with Leishmania amazonensis. MHC class I presentation of GP46/M-2 by infected macrophages can be blocked by treatment with brefeldin A and also by inhibitors of the cytosolic multicatalytic proteasome, N-acetyl-L- leucinyl-L-leucinal-L-norleucinal and N-acetyl-L-leucinyl-L- leucinylmethional. These results suggest that this leishmanial Ag is processed in the macrophage cytoplasm and is presented to CD8+ T cells via the classical pathway of MHC class I presentation. The relevance of these findings as they impact on our understanding of the biology of the parasite within the macrophage is discussed.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Bertholet, R. Goldszmid, A. Morrot, A. Debrabant, F. Afrin, C. Collazo-Custodio, M. Houde, M. Desjardins, A. Sher, and D. Sacks
Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo
J. Immunol., September 15, 2006; 177(6): 3525 - 3533.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Bertholet, A. Debrabant, F. Afrin, E. Caler, S. Mendez, K. S. Tabbara, Y. Belkaid, and D. L. Sacks
Antigen Requirements for Efficient Priming of CD8+ T Cells by Leishmania major-Infected Dendritic Cells
Infect. Immun., October 1, 2005; 73(10): 6620 - 6628.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Olivier, D. J. Gregory, and G. Forget
Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View
Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. E. Uzonna, K. L. Joyce, and P. Scott
Low Dose Leishmania major Promotes a Transient T Helper Cell Type 2 Response That Is Down-regulated by Interferon {gamma}-producing CD8+ T Cells
J. Exp. Med., June 7, 2004; 199(11): 1559 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Meier, M. Svensson, and P. M. Kaye
Leishmania-Induced Inhibition of Macrophage Antigen Presentation Analyzed at the Single-Cell Level
J. Immunol., December 15, 2003; 171(12): 6706 - 6713.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Colmenares, P. E. Kima, E. Samoff, L. Soong, and D. McMahon-Pratt
Perforin and Gamma Interferon Are Critical CD8+ T-Cell-Mediated Responses in Vaccine-Induced Immunity against Leishmania amazonensis Infection
Infect. Immun., June 1, 2003; 71(6): 3172 - 3182.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
A. L. ABREU-SILVA, K. S. CALABRESE, R. C. TEDESCO, R. A. MORTARA, and S. C. G. DA COSTA
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN EXPERIMENTAL INFECTION WITH LEISHMANIA (LEISHMANIA) AMAZONENSIS
Am J Trop Med Hyg, June 1, 2003; 68(6): 661 - 665.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. M. Da-Cruz, R. Bittar, M. Mattos, M. P. Oliveira-Neto, R. Nogueira, V. Pinho-Ribeiro, R. B. Azeredo-Coutinho, and S. G. Coutinho
T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after Therapy
Clin. Vaccine Immunol., March 1, 2002; 9(2): 251 - 256.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Huber, E. Timms, T. W. Mak, M. Rollinghoff, and M. Lohoff
Effective and Long-Lasting Immunity against the Parasite Leishmania major in CD8-Deficient Mice
Infect. Immun., August 1, 1998; 66(8): 3968 - 3970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.